Literature DB >> 22611052

Approach to improve compound recovery in a high-throughput Caco-2 permeability assay supported by liquid chromatography-tandem mass spectrometry.

Xianmei Cai1, Aaron Walker, Charles Cheng, Anthony Paiva, Ying Li, Janet Kolb, John Herbst, Wilson Shou, Harold Weller.   

Abstract

The Caco-2 cell culture system is widely employed as an in vitro model for prediction of intestinal absorption of test compounds in early drug discovery. Poor recovery is a commonly encountered issue in Caco-2 assay, which can lead to difficulty in data interpretation and underestimation of the apparent permeability of affected compounds. In this study, we systematically investigated the potential sources of compound loss in our automated, high-throughput Caco-2 assay, sample storage, and analysis processes, and as a result found the nonspecific binding to various plastic surfaces to be the major cause of poor compound recovery. To minimize the nonspecific binding, we implemented a simple and practical approach in our assay automation by preloading collection plates with organic solvent containing internal standard prior to transferring incubations samples. The implementation of this new method has been shown to significantly increase recovery in many compounds previously identified as having poor recovery in the Caco-2 permeability assay. With improved recovery, permeability results were obtained for many compounds that were previously not detected in the basolateral samples. In addition to recovery improvement, this new approach also simplified sample preparation for liquid chromatography-tandem mass spectrometric analysis and therefore achieved time and cost savings for the bioanalyst.
Copyright © 2012 Wiley Periodicals, Inc.

Mesh:

Year:  2012        PMID: 22611052     DOI: 10.1002/jps.23194

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.

Authors:  Richard A Graves; Grace A Ledet; Elena Y Glotser; Demaurian M Mitchner; Levon A Bostanian; Tarun K Mandal
Journal:  Eur J Pharm Sci       Date:  2015-04-28       Impact factor: 4.384

2.  Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles.

Authors:  Grace A Ledet; Richard A Graves; Elena Y Glotser; Tarun K Mandal; Levon A Bostanian
Journal:  Int J Pharm       Date:  2014-12-24       Impact factor: 5.875

3.  Dual Inhibitors of 8-Oxoguanine Surveillance by OGG1 and NUDT1.

Authors:  Yu-Ki Tahara; Anna M Kietrys; Marian Hebenbrock; Yujeong Lee; David L Wilson; Eric T Kool
Journal:  ACS Chem Biol       Date:  2019-10-29       Impact factor: 5.100

Review 4.  Current status and future directions of high-throughput ADME screening in drug discovery.

Authors:  Wilson Z Shou
Journal:  J Pharm Anal       Date:  2020-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.